Search

everythinglearnresearchcommunity

for

Search:↓

The treatment showed significant hair regrowth in alopecia areata patients without side effects.

Tofacitinib helped a young woman's severe hair loss and arthritis but not her plaque psoriasis.

Tofacitinib helped a woman regrow her hair without relapses after other treatments failed.

Tofacitinib is a safe and effective treatment for hair loss in children with Alopecia Areata.

A new carrier improves skin delivery of tofacitinib for treating inflammatory skin diseases.

Tofacitinib may help treat hair loss in children with alopecia areata.

Topical tofacitinib helped a man with severe scalp condition after other treatments failed.

Tofacitinib helped an 8-year-old child recover from a type of hair loss that is hard to treat.

Tofacitinib is effective for treating alopecia totalis and universalis, with some patients experiencing significant hair regrowth.

Topical tofacitinib may help regrow hair in children with alopecia totalis.

Tofacitinib may slow hair loss in scarring alopecias but is unlikely to regrow significant hair.

Oral tofacitinib is a promising treatment for beard hair loss in alopecia areata.

Tofacitinib may help hair regrowth in alopecia areata, but more research is needed.

Topical tofacitinib cream may help treat certain hair loss conditions with fewer risks.

A woman's vitiligo improved with tofacitinib treatment, and her skin color remained even after stopping the medication, but there are concerns about cancer risk.

Tofacitinib effectively regrows hair in alopecia areata but may need continuous use.

Using finasteride with TIP extends time off period for prostate cancer patients.

Tofacitinib, a medication for arthritis, showed potential for treating severe hair loss in a small Brazilian case series, but more research is needed.

Tofacitinib, a JAK inhibitor, improved hair regrowth in most patients with severe alopecia areata and had minimal side effects.

A woman's eyelash regrowth was successful using tofacitinib solution for alopecia areata.

Getting insurance to cover the hair loss treatment tofacitinib is hard because it's not officially approved for that use.

A new treatment using nanoparticles can effectively prevent and reduce hair loss caused by chemotherapy.

Both baricitinib and tofacitinib effectively reduce alopecia areata severity, with tofacitinib showing more improvement over longer use.

TAK-279 effectively reduces psoriasis symptoms and is safe.

Tofacitinib nanoparticles can safely and effectively treat alopecia areata by targeting hair follicles.

Deleting the Trf1 protein in mice is safe and may help prevent cancer without major side effects.

Tofacitinib helped regrow hair in patients with alopecia, with few side effects.

Topical tofacitinib shows promise as a future treatment for alopecia areata.